What are the recommendations for managing Wellbutrin (bupropion) in patients undergoing surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Perioperative Management of Wellbutrin (Bupropion)

Continue Wellbutrin (bupropion) through the perioperative period without interruption. Stopping antidepressants before surgery increases the risk of depression relapse, delirium, and confusion without reducing anesthetic complications 1.

Evidence-Based Recommendation

The strongest evidence comes from a randomized controlled trial demonstrating that patients who discontinued antidepressants 72 hours before surgery experienced significantly worse outcomes 1:

  • 20% developed worsening depressive symptoms (vs. 5% who continued therapy, p=0.04) 1
  • 30% experienced perioperative delirium or confusion (vs. 13% who continued therapy, p=0.05) 1
  • No increase in hypotension or arrhythmias occurred in patients who continued antidepressants 1

Key Clinical Points

Preoperative Management

  • Do not discontinue bupropion before elective or emergent surgery 1
  • Administer the patient's usual morning dose on the day of surgery with a sip of water 1
  • Document continuation in the anesthetic record 2

Intraoperative Considerations

  • Bupropion does not increase the risk of hemodynamic instability during anesthesia 1
  • Standard anesthetic techniques are appropriate 1
  • Monitor for typical cardiovascular responses to anesthesia as you would in any patient 2

Postoperative Management

  • Resume bupropion as soon as the patient can tolerate oral medications 1
  • If NPO status is prolonged beyond 24 hours, consider alternative routes or temporary substitution after consulting psychiatry 3
  • Monitor for mood changes or withdrawal symptoms if medication is inadvertently held 4

Critical Warnings

Abrupt discontinuation of bupropion can precipitate withdrawal symptoms including irritability, anxiety, insomnia, headache, and generalized pain 4. These symptoms complicate postoperative recovery and pain assessment 4.

Withdrawal from antidepressants with short half-lives may cause cardiovascular instability, particularly hypotension requiring vasopressor support 3. While this has been documented primarily with SSRIs and mirtazapine, the principle applies to maintaining all chronic antidepressant therapy 3.

Common Pitfalls to Avoid

  • Do not reflexively hold all psychiatric medications based on outdated perioperative protocols 1
  • Do not confuse bupropion (Wellbutrin) with buprenorphine (Suboxone/Subutex), which requires entirely different perioperative management 5, 6
  • Do not assume withdrawal symptoms are simply postoperative pain if bupropion is inadvertently discontinued 4

Special Consideration: Naltrexone-Bupropion Combination (Contrave)

If the patient is taking naltrexone-bupropion combination therapy for weight management, this presents a unique challenge due to the opioid antagonist component 7:

  • The naltrexone component blocks opioid analgesia and requires discontinuation 72 hours before surgery 7
  • Plan aggressive multimodal analgesia with regional techniques, NSAIDs, acetaminophen, and ketamine 7
  • Expect inadequate pain control with standard opioid doses even after naltrexone discontinuation 7
  • Coordinate with pain management and the prescribing physician preoperatively 7

References

Research

Antidepressant treatment for chronic depressed patients should not be discontinued prior to anesthesia.

Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2002

Research

Stopping and restarting medications in the perioperative period.

The Medical clinics of North America, 2001

Research

Hypotension following cardiac surgery associated with paroxetine and mirtazapine withdrawal.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2008

Research

Bupropion-Associated Withdrawal Symptoms: A Case Report.

Primary care companion to the Journal of clinical psychiatry, 1999

Guideline

Anesthetic Implications of Patients on Buprenorphine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Perioperative Management of Buprenorphine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.